Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

NaviFast 6D for Limb Length Measurement During Total Hip Arthroplasty (NaviFast6D)

14 мая 2026 г. обновлено: Lodz University of Technology

Orthopedic Miniature Measuring Arm for Assessing Selected Parameters During Total Hip Arthroplasty

This multicenter clinical investigation evaluated the NaviFast 6D orthopedic miniature measuring arm during total hip arthroplasty. NaviFast 6D is an intraoperative measuring device intended to help orthopedic surgeons assess changes in lower limb length and hip offset during surgery.

The study was conducted in adult patients undergoing primary total hip arthroplasty. It included two phases. In the first phase, the device was used to verify functionality, usability, and measurement accuracy without influencing surgical decisions. In the second phase, surgeons could use the intraoperative measurements provided by NaviFast 6D when selecting trial and final implant components.

The main objectives were to compare NaviFast 6D measurements with radiographic measurements of limb length change and to compare postoperative leg length discrepancy between patients treated with NaviFast 6D and a control group treated using conventional clinical assessment. The study also assessed the impact of device use on surgical time and recorded device-related and procedure-related safety events.

Обзор исследования

Статус

Завершенный

Условия

Вмешательство/лечение

Подробное описание

This was a multicenter, controlled, open-label, non-randomized clinical investigation of the NaviFast 6D orthopedic miniature measuring arm in patients undergoing primary total hip arthroplasty.

NaviFast 6D is an active, invasive surgical medical device with a measuring function. The device consists of pelvic and femoral fixation elements, an articulated measuring arm with motion sensors, and a microprocessor unit with a display. It is intended for professional use by orthopedic surgeons during total hip arthroplasty to provide intraoperative information on changes in lower limb length and hip offset relative to the pre-implantation state.

During the procedure, fixation elements were attached to the pelvis and femur using cannulated screws. The measuring arm connected the two fixation elements and recorded relative displacement in six degrees of freedom. A baseline measurement was taken before implantation. After preparation of the acetabulum and femur and placement of trial components, the measuring arm was used again to assess the change in limb length and offset. The surgeon could then consider these measurements before final implantation.

The clinical investigation was conducted in two phases. Phase I focused on verification of device functionality, safety, usability, optimization of the measurement procedure, and comparison of NaviFast 6D measurements with reference radiographic measurements. During Phase I, surgical decisions were based on standard clinical assessment rather than on the device measurements. Phase II evaluated use of the final device configuration in clinical practice, with surgeons allowed to use NaviFast 6D measurements when selecting implant components, unless clinical assessment contradicted the measurement.

The primary objective of Phase I was to determine the accuracy of NaviFast 6D measurements of limb length change and hip offset compared with radiographic reference measurements. The primary objective of Phase II was to compare postoperative leg length discrepancy in patients treated with NaviFast 6D with a control group treated using conventional clinical assessment only.

Secondary objectives included assessment of the accuracy of the radiographic reference measurement method using the LLDcalc.com software, estimation of the additional operative time associated with use of NaviFast 6D, and identification and classification of adverse events or device deficiencies associated with use of the measuring arm.

The study population consisted of adult patients undergoing primary total hip arthroplasty. Patients were enrolled at participating clinical centers in Poland. The overall study period covered recruitment, surgical procedures, and postoperative observation from May 9, 2023 to August 30, 2024.

Тип исследования

Интервенционный

Регистрация (Действительный)

84

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

  • Польша
      • Zakopane, Польша
        • University Orthopaedic and Rehabilitation Hospital
    • Greater Poland Voivodeship
      • Kalisz, Greater Poland Voivodeship, Польша
        • Wojewódzki Szpital Zespolony im. L. Perzyny
    • Lublin Voivodeship
      • Lublin, Lublin Voivodeship, Польша
        • Military Clinical Hospital in Lublin
    • Łódź Voivodeship
      • Pabianice, Łódź Voivodeship, Польша
        • Pabianice Medical Center

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

  • Взрослый
  • Пожилой взрослый

Принимает здоровых добровольцев

Нет

Описание

Inclusion Criteria:

  • Patients scheduled for primary total hip arthroplasty.
  • Male or female patients.
  • Age 20 to 85 years.
  • No previous surgical procedures in the affected hip joint.
  • Ability and willingness to provide informed consent for participation in the clinical investigation.

Exclusion Criteria:

  • Lack of informed consent to participate in the clinical investigation.
  • Pregnancy.
  • Femoral neck fracture.
  • Pertrochanteric femoral fracture.
  • Pseudarthrosis of the femoral neck.
  • Traumatic or post-traumatic changes of the proximal femur or acetabular region.
  • Bone neoplasm.
  • Bone infection.
  • Advanced osteoporosis.

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Другой
  • Распределение: Нерандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Нет (открытая этикетка)

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: NaviFast 6D Measuring Arm
Patients undergoing primary total hip arthroplasty with intraoperative use of the NaviFast 6D orthopedic miniature measuring arm. The device was used to measure changes in lower limb length and hip offset during surgery. In Phase I, measurements were recorded but did not guide surgical decisions. In Phase II, surgeons could use NaviFast 6D measurements when selecting trial and final implant components.
Устройство: NaviFast 6D Measuring Arm
NaviFast 6D is an orthopedic miniature measuring arm used intraoperatively during total hip arthroplasty to measure changes in lower limb length and hip offset relative to the pre-implantation state. The device includes pelvic and femoral fixation elements, an articulated measuring arm with motion sensors, and a microprocessor unit with a display.
Активный компаратор: Conventional Clinical Assessment
Patients undergoing primary total hip arthroplasty using conventional intraoperative clinical assessment only, without use of the NaviFast 6D measuring arm. This group served as the control group for comparison of postoperative leg length discrepancy.
Процедура: Conventional Clinical Assessment During Total Hip Arthroplasty
Standard intraoperative clinical assessment used during primary total hip arthroplasty without use of the NaviFast 6D measuring arm. Assessment of limb length and hip biomechanics was based on the surgeon's conventional visual, palpatory, and clinical judgment during the procedure.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Accuracy of NaviFast 6D Measurement of Lower Limb Length Change
Временное ограничение: Preoperative pelvic radiograph, an average of 1 day before surgery; intraoperative NaviFast 6D measurement during surgery; and postoperative pelvic radiograph, an average of 1 day after surgery
Accuracy of intraoperative lower limb length change measurement performed with the NaviFast 6D measuring arm, assessed by comparing NaviFast 6D measurements with reference radiographic measurements obtained from preoperative and postoperative pelvic radiographs analyzed using LLDcalc.com software. The endpoint was expressed as the root mean square difference between NaviFast 6D and radiographic measurements in millimeters.
Preoperative pelvic radiograph, an average of 1 day before surgery; intraoperative NaviFast 6D measurement during surgery; and postoperative pelvic radiograph, an average of 1 day after surgery
Postoperative Leg Length Discrepancy Compared With Control Group
Временное ограничение: At postoperative pelvic radiographic assessment, an average of 1 day after surgery
Postoperative leg length discrepancy was compared between patients undergoing total hip arthroplasty with intraoperative use of NaviFast 6D and patients undergoing total hip arthroplasty using conventional intraoperative clinical assessment only. Leg length discrepancy was assessed on postoperative radiographs and expressed in millimeters.
At postoperative pelvic radiographic assessment, an average of 1 day after surgery

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Accuracy of Radiographic Reference Measurement Using LLDcalc.com
Временное ограничение: At radiographic image analysis of paired preoperative or paired postoperative pelvic radiographs obtained in the same clinical state within approximately 1 to 3 months
Accuracy of the radiographic reference method for assessing leg length discrepancy and hip offset was evaluated using LLDcalc.com software. The analysis assessed the repeatability of measurements performed on radiographs obtained in the same clinical state and expressed results as root mean square differences in millimeters.
At radiographic image analysis of paired preoperative or paired postoperative pelvic radiographs obtained in the same clinical state within approximately 1 to 3 months
Additional Operative Time Associated With NaviFast 6D Use
Временное ограничение: During the surgical procedure
Additional operative time associated with use of the NaviFast 6D measuring arm was estimated based on the time required for device fixation, intraoperative measurement procedures, and potential implant component adjustment based on device readings.
During the surgical procedure
Adverse Events and Device Deficiencies Associated With NaviFast 6D
Временное ограничение: From the start of the surgical procedure through postoperative Day 2
Adverse events, serious adverse events, device deficiencies, and corrective actions associated with intraoperative use of the NaviFast 6D measuring arm were recorded and classified throughout the clinical investigation.
From the start of the surgical procedure through postoperative Day 2

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Lodz University of Technology

Следователи

  • Главный следователь: Ireneusz Urbaniak, MD, PhD, Wojewódzki Szpital Zespolony im. L. Perzyny

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

9 мая 2023 г.

Первичное завершение (Действительный)

30 августа 2024 г.

Завершение исследования (Действительный)

30 августа 2024 г.

Даты регистрации исследования

Первый отправленный

5 мая 2026 г.

Впервые представлено, что соответствует критериям контроля качества

14 мая 2026 г.

Первый опубликованный (Действительный)

19 мая 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

19 мая 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

14 мая 2026 г.

Последняя проверка

1 мая 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Ключевые слова

Дополнительные соответствующие термины MeSH

Другие идентификационные номера исследования

  • PBK 1.3
  • POIR.01.01.01-00-0290/21 (Другой номер гранта/финансирования: National Centre for Research and Development)

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Описание плана IPD

Individual participant data will not be shared because the dataset contains sensitive clinical and radiographic information, and no formal individual participant data sharing plan or participant consent for such sharing was defined in the study protocol. Aggregate results will be reported in publications.

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться